Liver
Surgery after systemic therapy delays treatment failure in advanced liver cancer, phase 3 trial finds

  • September 10

Colon
Blood test detected 81% of advanced adenomas in DENEB study

  • September 9

GI faces another round of Medicare cuts under proposed 2027 rules

  • September 8

Liver
Most US adults lack serologic immunity to hepatitis A and B

  • September 8

Colon

AI's deskilling question has a GI metric: ADR

  • September 11

As medicine debates whether AI could erode clinical skills, one multicenter study found unassisted ADR fell 6 percentage points after CADe was introduced.

BROWSE BY TOPICS

The New Gastroenterologist

Substance use disorders in gastroenterology and hepatology: A practical guide for the general gastroenterologist

  • August 3

  • by Isabelle S. Byers, MD, Michelle Russin, MD, Sasha Deutsch-Link, MD, MSCR

GI and liver complications often bring these patients in first, and the authors say gastroenterologists are well placed to screen and treat.

Esophagus
Bridging the rural divide: Building a motility center in a critical access hospital

  • August 3

  • by Amber Charoen, MD, W. Michael McDonnell, MD, AGAF

“If large urban centers can run comprehensive motility labs, why can't a critical access hospital?”

Is professional coaching worth it? A practical guide for early-career gastroenterologists

  • August 3

  • by Mariam Naveed, MD, FACG, Kathryn E. Hutchins, MD, FACG

Two program directors on why coaching belongs at the start of a GI career, not after something has already gone wrong.

The Latest

September 11
Colon
AI's deskilling question has a GI metric: ADR

  • by Julia Cipriano

As medicine debates whether AI could erode clinical skills, one multicenter study found unassisted ADR fell 6 percentage points after CADe was introduced.

September 10
Liver
Surgery after systemic therapy delays treatment failure in advanced liver cancer, phase 3 trial finds

  • by Doug Brunk

“Continuing systemic therapy should no longer be the default option for patients who respond favorably.”

September 9
Colon
Blood test detected 81% of advanced adenomas in DENEB study

  • by Julia Cipriano

The assay cleared its sensitivity target for early-stage cancer but fell short of the study's prespecified bar for precancerous lesions.

September 8
Liver
Most US adults lack serologic immunity to hepatitis A and B

  • by Julie Greenbaum

“This gap is particularly important because the lowest levels of protection were seen among groups most vulnerable to severe outcomes,” said study author Giovanni A. Roldan, MD.

September 8
Small bowel
DGBI burden holds steady under Rome V, but IBS prevalence doubles

  • by Doug Brunk

About four in 10 adults across 15 countries met criteria for at least one gut-brain disorder — nearly identical to Rome IV — while looser pain thresholds more than doubled the share meeting IBS criteria.